eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hartnup disease |
| Comorbidity | C0007113|rectal carcinoma |
| Sentences | 1 |
| PubMedID- 21399234 | Vectibix® is indicated as a single agent for the treatment of egfr-expressing, metastatic colorectal carcinoma with disease progression on or following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens [60-62]. |
Page: 1